REFERENCEGoogle News, SEBI·2d★ ON YOUR LIST
Upcoming IPO: Electrical products maker Biocon Electric files DRHP with SEBI - Moneycontrol.comStock · NSE
BIOCON
369.80▼ 0.90 (-0.24%)Last 2 days · 15m candles9/10/2026, 02:01:27
Open: 368.70High: 371.70Low: 365.95Prev: 370.70
Positive
13
Neutral
16
Negative
1
News mentioning BIOCON
Sentiment: +40%← All news
VERIFIEDET Markets·3d★ ON YOUR LIST
IPO Ahead! Electrical products maker Biocon Electric files draft papers with SebiAI summary· NEUTRAL
- ·Biocon Electric has filed its Draft Red Herring Prospectus (DRHP) with the Securities and Exchange Board of India (Sebi).
- ·The Initial Public Offering (IPO) comprises 59 lakh shares, including a fresh issue and an offer for sale (OFS).
- ·The company intends to utilize the proceeds from the fresh issue mainly for working capital requirements.
REFERENCEGoogle News, SEBI·3d★ ON YOUR LIST
Electrical products maker Biocon Electric files DRHP with SEBI to launch IPO; key details - Business TodayVERIFIEDET Finance·17d★ ON YOUR LIST
Biocon arm gets positive EMA panel recommendation for breast cancerbiosimilar PebrilzoAI summary· POSITIVE
- ·Biocon Biologics' Pertuzumab biosimilar, Pebrilzo, received a positive recommendation from the EMA's CHMP.
- ·The recommendation is for the treatment of HER2-positive breast cancer.
- ·The European Commission will make the final decision on marketing authorisation in the EU.
VERIFIEDET Markets·29d★ ON YOUR LIST
Biocon shares rise 3% after Rs 638-crore block deal; Active Pine likely sellerAI summary· POSITIVE
- ·Biocon shares increased by 3% following a block deal of approximately 1.65 crore shares.
- ·Investor Active Pine was reportedly considering selling up to 1.66 crore shares, representing about 1% of the company's stake.
- ·The potential sale was valued at around Rs 638 crore, with a floor price of Rs 385 per share.
VERIFIEDET Stocks·29d★ ON YOUR LIST
Biocon shares rise 3% after Rs 638-crore block deal; Active Pine likely sellerAI summary· POSITIVE
- ·Biocon shares increased by 3% following a block deal of approximately 1.65 crore shares.
- ·Investor Active Pine was reportedly selling up to 1.66 crore shares, representing about a 1% stake.
- ·The block deal was valued at around Rs 638 crore with a floor price of Rs 385 per share.
REFERENCEGoogle News, India stocks·30d★ ON YOUR LIST
Stocks to Watch Today: Biocon, Fermenta Biotech, Shadowfax, Innovision, Enviro Infra Engineers, Moschip... - Moneycontrol.comREFERENCEGoogle News, India stocks·30d★ ON YOUR LIST
Stocks to Watch Today: Biocon, Fermenta Biotech, Shadowfax, Innovision, Enviro Infra Engineers, Moschip Technologies, Raymond in focus on 09 September - Moneycontrol.comVERIFIEDET Stocks·30d★ ON YOUR LIST
Stocks in news: Biocon, Bank of Baroda, TCS, Sanofi India and Tata CapitalAI summary· NEGATIVE
- ·Indian equity markets reached a seven-week low on Tuesday.
- ·Bank of Baroda announced plans to divest its interest in the NSE.
- ·TCS secured a major contract.
REFERENCEGoogle News, NIFTY/SENSEX·30d★ ON YOUR LIST
Top 10@10: Nifty at 3-month low, Biocon’s $1 billion insulin bet, GFF 2026 kicks off and more - LinkedInVERIFIEDET Markets·30d★ ON YOUR LIST
Biocon shares: Active Pine may divest up to 1% equity worth Rs 638 crore via block dealAI summary· NEUTRAL
- ·Active Pine plans to sell up to 1.66 crore Biocon shares valued at Rs 638 crore.
- ·The block deal is expected to occur at Rs 385 per share.
- ·This comes as Biocon announces a 10-year Brazil partnership for Pertuzumab.
VERIFIEDET Stocks·30d★ ON YOUR LIST
Biocon shares rise 2% on 10-year Pertuzumab supply deal for breast cancer therapy in BrazilAI summary· POSITIVE
- ·Biocon shares increased by 2% following a 10-year supply agreement for Pertuzumab in Brazil.
- ·The company, in a consortium with Bahiafarma and Bionovis, secured full allocation under Brazil's PDP programme.
- ·This agreement will provide access to approximately 70% of the public-sector demand for the breast cancer therapy.
VERIFIEDET Finance·30d★ ON YOUR LIST
Biocon signs 10-year Brazil supply deal for Pertuzumab breast cancer drugAI summary· NEUTRAL
- ·Biocon has entered into a ten-year agreement in Brazil for Pertuzumab.
- ·The deal was facilitated through collaborations with Bahiafarma and Bionovis.
- ·The agreement grants exclusive rights to supply Brazil's public healthcare sector with phased production localization planned.
VERIFIEDET Finance·44d★ ON YOUR LIST
Biocon arm gets Japan nod for cancer drug pegfilgrastim biosimilarAI summary· POSITIVE
- ·Biocon Biologics has received marketing approval for its pegfilgrastim biosimilar in Japan.
- ·The drug is used to reduce infection risks after chemotherapy.
- ·Sandoz KK will exclusively promote and distribute the biosimilar in Japan.
VERIFIEDMint Money·46d★ ON YOUR LIST
Mutual funds bet across market caps in July 2026: Torrent Pharma, Biocon and Diamond Power among top stock buysAI summary· NEUTRAL
- ·Mutual funds increased exposure to large-, mid-, and small-cap stocks in July 2026.
- ·Buying activity was observed across sectors such as banking, financial services, and consumer services.
- ·Torrent Pharma, Biocon, and Diamond Power were among the top stock buys for mutual funds.
VERIFIEDET Stocks·51d★ ON YOUR LIST
Biocon shares rise 2% after USFDA approval for Yesintek single-dose prefilled autoinjectorAI summary· POSITIVE
- ·Biocon shares increased by 2% following the USFDA approval.
- ·The approval is for Yesintek single-dose prefilled autoinjectors in two strengths.
- ·This approval enhances Biocon's US immunology product offerings.
VERIFIEDMint Markets·63d★ ON YOUR LIST
Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy today — 7 August 2026AI summary· NEUTRAL
- ·Sumeet Bagadia recommends five breakout stocks to buy today.
- ·The recommended stocks are Kalyan Jewellers India, Bharat Dynamics, Union Bank of India, Garden Reach Shipbuilders & Engineers, and Biocon.
- ·The recommendations are for 7 August 2026.
VERIFIEDMint Companies·63d★ ON YOUR LIST
US generics tariffs more negotiation tactic than real threat: Biocon’s Kiran Mazumdar-ShawAI summary· NEUTRAL
- ·Biocon's Kiran Mazumdar-Shaw views US generics tariffs as a negotiation tactic.
- ·The company is in a wait-and-watch mode regarding the tariffs.
- ·Biocon is exploring partnerships for US manufacturing if necessary.
REFERENCEGoogle News, India stocks·64d★ ON YOUR LIST
Stocks to Watch Today: Aurobindo Pharma, Cohance, Hindalco, Cummins, PB Fintech, Navin Fluorine, Biocon,... - Moneycontrol.comVERIFIEDMint Markets·64d★ ON YOUR LIST
Q1 results 2026: Power Grid to PB Fintech among companies to declare Q1 results today; full list hereAI summary· NEUTRAL
- ·Power Grid Corporation of India will report its Q1 results FY27 today.
- ·Cummins India is among the companies scheduled to declare their Q1 results FY27 today.
- ·PB Fintech will also announce its Q1 results for FY27 today.
VERIFIEDET Finance·71d★ ON YOUR LIST
Biocon gets Health Canada nod for Yesintek autoinjector penAI summary· POSITIVE
- ·Biocon has received Health Canada approval for its Yesintek autoinjector.
- ·The autoinjector is indicated for psoriasis, psoriatic arthritis, and Crohn's disease.
- ·This approval aims to enhance Biocon's immunology product offerings in Canada.
VERIFIEDMint Markets·76d★ ON YOUR LIST
Stocks to buy for short term: Biocon among 3 shares Ajit Mishra of Religare Broking recommends for next 1-2 weeksAI summary· POSITIVE
- ·Ajit Mishra of Religare Broking recommends Biocon, Mahindra, and United Spirits for short-term gains.
- ·These stocks have favorable technical setups.
- ·The stocks show potential for upward momentum in the next 1-2 weeks.
VERIFIEDET Stocks·84d★ ON YOUR LIST
BHEL among 6 midcap stocks that hit 52-week highs and rallied up to 20% in a monthAI summary· POSITIVE
- ·Six BSE 150 MidCap stocks, including BHEL, reached new 52-week highs.
- ·These stocks experienced rallies of up to 20% within the last month.
- ·The performance indicates strong buying interest and sustained bullish momentum in the midcap segment.
VERIFIEDET Markets·84d★ ON YOUR LIST
BHEL among 6 midcap stocks that hit 52-week highs and rallied up to 20% in a monthAI summary· POSITIVE
- ·Six BSE 150 MidCap stocks, including BHEL, reached new 52-week highs.
- ·These stocks experienced rallies of up to 20% within the last month.
- ·The upward movement indicates strong buying interest and sustained bullish momentum.
VERIFIEDET Markets·85d★ ON YOUR LIST
Biocon among 4 stocks showing bullish RSI upswingAI summary· POSITIVE
- ·Four Nifty500 stocks gained over 4% on July 14.
- ·These stocks appeared in the RSI Trending Up scan, indicating improving momentum.
- ·The Relative Strength Index (RSI) moved above 50, signaling strengthening price action.
VERIFIEDET Stocks·86d★ ON YOUR LIST
Rs 1,839 crore Biocon block deal: ICICI Pru MF biggest buyer along with Citi and Goldman SachsAI summary· NEUTRAL
- ·Mylan sold a stake in Biocon worth ₹1,839 crore via a block deal.
- ·ICICI Prudential Mutual Fund was the largest buyer in the block deal.
- ·Other institutional investors including mutual funds, insurers, and foreign investors participated.
VERIFIEDET Stocks·86d★ ON YOUR LIST
Biocon among 4 midcap stocks that hit 52-week highs and rallied up to 21% in a monthAI summary· POSITIVE
- ·Four BSE 150 Midcap stocks, including Biocon, reached new 52-week highs on Tuesday.
- ·These stocks showed strong buying interest and bullish momentum.
- ·The rally occurred despite a 561-point fall in the Sensex on the same day.
VERIFIEDET Stocks·86d★ ON YOUR LIST
Biocon shares jump 6% as Mylan likely exits drugmaker after Rs 3,481 crore stake saleAI summary· POSITIVE
- ·Biocon shares surged over 6% on Tuesday.
- ·Mylan, owned by Viatris, plans to sell its 5.64% stake in Biocon.
- ·Block deals involving nearly nine crore shares were observed in early trading.
REFERENCEGoogle News, India stocks·86d★ ON YOUR LIST
Stock Market Live: Nifty below 24,100, Sensex down 450 pts; HCLTech down 2%, Biocon up 3% - Moneycontrol.comREFERENCEGoogle News, NIFTY/SENSEX·86d★ ON YOUR LIST
GIFT Nifty Slips 165 Points; HCL Tech, Biocon Stocks in Focus - NiftyTrader